Skip to main content
Premium Trial:

Request an Annual Quote

Greiner Bio-One, EBIMed, National Center for Biotechnology Information, PerkinElmer, Andrew MacDonald

Premium

New Products

Greiner Bio-One late last month introduced its line of streptavidin-coated microplates through its Longwood, Fla.-based US office.

The microplates are available in 96- and 384-well formats and use the streptavidin-biotin bond for bonding biotinylated protein, nucleic acid, and antigen-antibodies onto pre-coated streptavidin plates.


EBIMed, a document retrieval and extraction tool, is available from the European Bioinformatics Institute at http://www.ebi.ac.uk/Rebholz-srv/ebimed. The extracted information provides an overview on associations between UniProt proteins, GO annotations, drug names, and species, as well as links to the relevant sentences, the original abstracts, and the biological databases that contain them.


The National Center for Biotechnology Information has released the Flu Sequence Dataset Explorer, an interactive tool for performing preliminary analysis on protein and nucleotide sequences from the NCBI Influenza Sequence Database, at http://www.ncbi.nlm.nih.gov/genomes/DatasetExplorer/FLU/fluPage.cgi.


PerkinElmer launched its BioRobot Universal System "automated solution" for systems biology last week, the company said. The instrument provides a range of "ready-to-run" applications in 96-well format, including DNA and RNA purification, and PCR and RT-PCR, PerkinElmer said. Protein and sequencing applications will be available soon, the company said.

 

Movers & Shakers

Andrew MacDonald has become head of the new microarray technologies division of Genesis Diagnostics, said the Littleport, UK-based company which specializes in manufacturing ELISA-based diagnostic kits. He used to be a manager with Genomics Solutions.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.